3rd Quarter - Report

SIEMENS MEDICAL SOLUTIONS USA, INC for SIEMENS MEDICAL SOLUTIONS USA, INC

Period 3rd Quarter 2021 Filed Oct 20, 2021 Signed by Frederick Dombo

Official filing
Firm
SIEMENS MEDICAL SOLUTIONS USA, INC
Client
SIEMENS MEDICAL SOLUTIONS USA, INC
Income
—
Expenses
$420,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

Export of raw materials to China.

LobbyistCovered position, as disclosed
MARK ESHERICK —
ELEANOR WENNER KERR —

Contacted: U.S. Customs & Border Protection; SENATE; Commerce, Dept of (DOC); Agriculture, Dept of (USDA); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Justice, Dept of (DOJ); Homeland Security, Dept of (DHS)

Homeland Security HOM

National Interest Exemptions.

LobbyistCovered position, as disclosed
MARK ESHERICK —
ELEANOR WENNER KERR —

Contacted: SENATE; Homeland Security, Dept of (DHS); U.S. Customs & Border Protection; Commerce, Dept of (DOC); Food & Drug Administration (FDA); Justice, Dept of (DOJ); HOUSE OF REPRESENTATIVES; Agriculture, Dept of (USDA)

Health Issues HCR

HR 1319; American Rescue Plan Act of 2021; Covid-19 Testing: Policies associated with use of serology and antigen testing; S. 2209, Verifying Accurate Leading-Edge IVCT Development Act (VALID), A bill to amend the Federal Food, Drug, and Cosmetic Act to provide for the regulation of in vitro clinical tests, and for other purposes, HR 4128, A bill to amend the Federal Food, Drug, and Cosmetic Act to provide for the regulation of in vitro clinical tests, and for other purposes; Medical Device User Fee Agreement; Service of medical devices; Right to Repair; Artificial Intelligence for imaging devices; Cybersecurity for legacy imaging equipment

LobbyistCovered position, as disclosed
MARK ESHERICK —
ELEANOR WENNER KERR —

Contacted: SENATE; Agriculture, Dept of (USDA); Commerce, Dept of (DOC); Food & Drug Administration (FDA); Homeland Security, Dept of (DHS); HOUSE OF REPRESENTATIVES; U.S. Customs & Border Protection; Justice, Dept of (DOJ)

Bills named: H.R. 4128 (117th), S. 2209 (117th), H.R. 1319 (117th)

Medical/Disease Research/Clinical Labs MED

H.R. 4479 and S.2609, Facilitating Innovative Nuclear Diagnostics Act (FIND Act); Outreach to Congress to support letters to CMS opposing proposed Physician Fee Schedule payment cuts impacting providers of radiation therapy and medical imagining, and opposing CMS mandatory Radiation Oncology Alternative Payment Model (RO APM).

LobbyistCovered position, as disclosed
MARK ESHERICK —
ELEANOR WENNER KERR —

Contacted: HOUSE OF REPRESENTATIVES; Agriculture, Dept of (USDA); Homeland Security, Dept of (DHS); Food & Drug Administration (FDA); Commerce, Dept of (DOC); Justice, Dept of (DOJ); U.S. Customs & Border Protection; SENATE

Bills named: H.R. 4479 (117th), S. 2609 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.